Yahoo
NasdaqCM - Nasdaq Real Time Price USD

eXoZymes, Inc. (EXOZ)

6.71 -0.67 (-9.08%)
As of 9:58:36 AM EDT. Market Open.
Chart Range Bar
Loading chart for EXOZ
  • Previous Close 7.38
  • Open 6.62
  • Bid 8.20 x 900
  • Ask 7.60 x 100
  • Day's Range 6.62 - 6.90
  • 52 Week Range 4.35 - 18.40
  • Volume 1,184
  • Avg. Volume 9,572
  • Market Cap (intraday) 62.232M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -1.20
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

www.exozymes.com

32

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 8/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EXOZ
38.49%
S&P 500 (^GSPC)
11.86%

1-Year Return

EXOZ
27.98%
S&P 500 (^GSPC)
18.41%

3-Year Return

EXOZ
39.59%
S&P 500 (^GSPC)
74.97%

5-Year Return

EXOZ
39.59%
S&P 500 (^GSPC)
70.69%

Statistics

View More

Valuation Measures

Annual
As of 8/21/2026
  • Market Cap

    68.45M

  • Enterprise Value

    63.88M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    18.73

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -74.74%

  • Return on Equity (ttm)

    -187.16%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -10.19M

  • Diluted EPS (ttm)

    -1.20

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.65M

  • Total Debt/Equity (mrq)

    29.69%

  • Levered Free Cash Flow (ttm)

    -3.25M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

6.70 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: